Million, M., Giraud-Gatineau, A., Lagier, J., Parola, P., Gautret, P., & Raoult, D. (2021). Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. Travel Med Infect Dis.

Million, Matthieu, Audrey Giraud-Gatineau, Jean-Christophe Lagier, Philippe Parola, Philippe Gautret, و Didier Raoult. "Reply to Lebeaux D, Revest M. No Evidence of Clinical Benefits of Early Treatment of COVID-19 Patients With Hydroxychloroquine and Azithromycin." Travel Med Infect Dis 2021.

Million, Matthieu, et al. "Reply to Lebeaux D, Revest M. No Evidence of Clinical Benefits of Early Treatment of COVID-19 Patients With Hydroxychloroquine and Azithromycin." Travel Med Infect Dis 2021.